Pacira BioSciences (FRA:82P) Inventory Turnover: 0.24 (As of Mar. 2026)

What is Pacira BioSciences Inventory Turnover?

Pacira BioSciences FRA:82P +2.75% 75 Inventory Turnover is 0.24 as of Mar. 2026. GuruFocus rates FRA:82P with a GF Score™ of 75/100 and a GF Value™ of €25.72. The stock has 8 warning signs investors should review.

Inventory Turnover measures how fast the company turns over its inventory within a year. It is calculated as Cost of Goods Sold divided by Total Inventories. Pacira BioSciences's Cost of Goods Sold for the three months ended in Mar. 2026 was €31.5 Mil. Pacira BioSciences's Average Total Inventories for the quarter that ended in Mar. 2026 was €130.3 Mil. Pacira BioSciences's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.24.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Pacira BioSciences's Days Inventory for the three months ended in Mar. 2026 was 377.51.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Pacira BioSciences's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.85.

Pacira BioSciences (FRA:82P) Inventory Turnover Explanation

Inventory Turnover measures how fast the company turns over its inventory within a year. A higher Inventory Turnover means the company has light inventory. Therefore the company spends less money on storage, write downs, and obsolete inventory. If the inventory is too light, it may affect sales because the company may not have enough to meet demand.

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Pacira BioSciences's Days Inventory for the three months ended in Mar. 2026 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Mar. 2026 )	/	Cost of Goods Sold (Q: Mar. 2026 )	*	Days in Period
	=	130.3075	/	31.497	*	365 / 4
	=	377.51

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Pacira BioSciences's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	130.3075	/	153.43
	=	0.85

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Usually retailers pile up their inventories at holiday seasons to meet the stronger demand. Therefore, the inventory of a particular quarter of a year should not be used to calculate Inventory Turnover. An average inventory is a better indication.

Pacira BioSciences Inventory Turnover Related Terms

Pacira BioSciences Inventory Turnover Historical Data

* Premium members only.

The historical data trend for Pacira BioSciences's Inventory Turnover can be seen below:

Pacira BioSciences Inventory Turnover Chart

Pacira BioSciences Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Inventory Turnover

Get a 7-Day Free Trial

1.77

2.12

1.82

1.51

1.02

Pacira BioSciences Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Inventory Turnover	Get a 7-Day Free Trial															0.26	0.28	0.22	0.26	0.24

75GF Score

Pacira BioSciences Inc FRA:82P

Inventory Turnover is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Pacira BioSciences Inventory Turnover Calculation

Pacira BioSciences's Inventory Turnover for the fiscal year that ended in Dec. 2025 is calculated as

	Inventory Turnover (A: Dec. 2025 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (A: Dec. 2025 )	/ (	(Total Inventories (A: Dec. 2024 )	+	Total Inventories (A: Dec. 2025 ))	/	count )
=	127.886	/ (	(119.644	+	130.545)	/	2 )
=	127.886	/	125.0945
=	1.02

Pacira BioSciences's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

	Inventory Turnover (Q: Mar. 2026 )
=	Cost of Goods Sold	/	Average Total Inventories
=	Cost of Goods Sold (Q: Mar. 2026 )	/ (	(Total Inventories (Q: Dec. 2025 )	+	Total Inventories (Q: Mar. 2026 ))	/	count )
=	31.497	/ (	(130.545	+	130.07)	/	2 )
=	31.497	/	130.3075
=	0.24

Frequently Asked Questions Learn more about Inventory Turnover →

What does a Inventory Turnover of 0.24 mean?

Pacira BioSciences (FRA:82P) has a Inventory Turnover of 0.24 as of Mar. 2026. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Pacira BioSciences and its competitors.

Is Pacira BioSciences' Inventory Turnover too high?

Pacira BioSciences' current Inventory Turnover is 0.24. Overall, Pacira BioSciences has a GF Score™ of 75/100, reflecting its overall financial health beyond just this single metric.

How does Pacira BioSciences' Inventory Turnover compare to ETON and AMPH?

Pacira BioSciences' Inventory Turnover of 0.24 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Inventory Turnover for a Drug Manufacturers company?

A good Inventory Turnover depends on the Drug Manufacturers industry context. However, Inventory Turnover should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Inventory Turnover mean?

A high Inventory Turnover can signal that a stock is expensive relative to its fundamentals. Inventory turnover equals current-period cost of goods sold divided by average two-period total inventories. View historical data on Pacira BioSciences and its competitors. Pacira BioSciences's current Inventory Turnover is 0.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Pacira BioSciences stock overvalued right now?

Pacira BioSciences (FRA:82P) has a current Inventory Turnover of 0.24. The stock's GF Value™ is €25.72, compared to a current price of €22.40 — trading 12.9% below its estimated fair value. The current Inventory Turnover is 0.24. Pacira BioSciences' overall GF Score™ is 75/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Inventory Turnover calculated?

Inventory Turnover is calculated from a company's financial statements. For Pacira BioSciences (FRA:82P), the current Inventory Turnover is 0.24 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pacira BioSciences (FRA:82P) Overvalued in 2026?

Based on GuruFocus' analysis, Pacira BioSciences stock appears to be undervalued. The current stock price of €22.40 is trading 12.9% below its estimated GF Value™ of €25.72.

Key valuation signals for FRA:82P:

Inventory Turnover: 0.24
GF Value™: €25.72 vs. price of €22.40 (12.9% below fair value)
GF Score™: 75/100 with 8 warning signs

No single metric tells the full story. See the FRA:82P stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pacira BioSciences Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies ETON AMPH BIOA ESPR COLL ALVO PAHC IRWD XERS PRGO XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges PCRX:USA 82P:Germany

Address 2000 Sierra Point Parkway, Suite 900, Brisbane, CA, USA, 94005

Website https://www.pacira.com

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

75GF Score

Get the complete analysis for FRA:82P

Inventory Turnover is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.40

Price

€25.72

GF Value

View FRA:82P Analysis

See Inventory Turnover data for all stocks →